Provider profile
Abzena.
Biologics CDMOs
Abzena describes cell line development (CHO), process development and cGMP drug substance manufacturing of monoclonal antibodies and recombinant proteins at San Diego, CA, using single-use bioreactors, for clinical and commercial supply. Its Bristol, PA site documents bioconjugation, ADC and highly potent manufacturing; a Cambridge, UK site covers discovery. Corporate headquarters are in Raleigh, NC.
- Website
- abzena.com (opens in a new tab)
- Sources reviewed
- November 4, 2026 · Source pages re-checked within 4 months
- First published
- November 3, 2026
This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.
Services and capabilities
Services and capabilities
- Analytical development and QC testing1,2
- Bioconjugation (ADC)3
- Cell line development7
- Formulation development4
- GMP drug substance manufacturing8Stated for biologics manufacturing at the San Diego, CA facilities
- Highly potent APIs1,3Stated for the Bristol, PA bioconjugate facility
- Process development5,6
- Stability studies1,2
- Technology transfer9
Platforms and methods
Drug substance / drug product
- Drug substance8Stated for biologics manufacturing at the San Diego, CA facilities
Development experience
Development experience
Locations
Locations
Quality and regulatory
Quality and regulatory
The provider’s own materials state that it works to, or holds, the following. ArgusBio has not inspected or audited these claims.
- GMP / cGMP8
Unknowns and questions to ask
Unknowns and questions to ask
Public sources rarely establish what matters most for a specific project. Confirm directly:
- Available capacity, slot timing and scale for your next campaign
- Recent experience with your specific modality and expression system or chemistry
- Regulatory inspection history of the specific site that would manufacture your product
- Technology-transfer approach, timeline and who owns the resulting process knowledge
- Analytical and QC release testing done in-house versus subcontracted
- Quality agreement terms, batch-failure responsibility and change-order mechanics
Evidence and sources
Evidence and sources
- 1Highly Potent API Development & Manufacturing | HPAPI Handling | Abzena (opens in a new tab)Abzena · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 2Bioconjugate & ADC Quality Control & Stability | Abzena (opens in a new tab)Abzena · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 3Bioconjugate, ADC & AOC Clinical Manufacturing | Abzena (opens in a new tab)Abzena · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 4Bioconjugate & ADC Formulation Development | Abzena (opens in a new tab)Abzena · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 5Locations | Abzena (opens in a new tab)Abzena · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 6Bioconjugate Process Development & Optimization | Abzena (opens in a new tab)Abzena · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 7Mammalian Cell Line Development Services | Abzena (opens in a new tab)Abzena · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 8cGMP Biologics Contract Manufacturing Services | Abzena (opens in a new tab)Abzena · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 9Bioconjugate & ADC Technology Transfer | Abzena (opens in a new tab)Abzena · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.
Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.
Contact
Contact
Contact the provider directly through its public contact page (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.
ArgusBio sourcing
Need help evaluating this provider or comparing alternatives.
Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.
Discuss a sourcing needWe work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.